SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001077183-21-000109
Filing Date
2021-04-21
Accepted
2021-04-21 18:09:42
Documents
1
Period of Report
2021-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_161904296587125.html 3  
1 FORM 3 wf-form3_161904296587125.xml 3 1653
  Complete submission text file 0001077183-21-000109.txt   3178
Mailing Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913
Business Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 9419231949
NEOGENOMICS INC (Issuer) CIK: 0001077183 (see all company filings)

IRS No.: 742897368 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8734 Services-Testing Laboratories

Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
Mallon Mark (Reporting) CIK: 0001763533 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35756 | Film No.: 21842674